Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Lineage–Specific Chimerism and Incidence of Graft-Failure Following T-Cell Replete Haploidentical Transplantation Using Post-Transplant Cyclophosphamide in Eighty-Nine Consecutive Patients From a Single-Center.

Amaani Hussain, Connie A. Sizemore, PharmD, Xu Zhang, PhD, Melissa Sanacore, PharmD, Stacey Brown, B.A., Karen Manion, RN, Lawrence E. Morris, Jr., MD, H. Kent Holland, MD, Scott R. Solomon, MD, Asad Bashey, MD, PhD

Blood (2012) 120 (21): 3030.

https://doi.org/10.1182/blood.V120.21.3030.3030

Published: 2012

Journal Articles

T-Cell Replete Haploidentical Transplantation Using Post-Transplant Cyclophosphamide Results in Equivalent Non-Relapse Mortality and Disease-Free Survival Compared to Transplantation From HLA-Identical Sibling and Matched Unrelated Donors: A Stratified Cox Model Analysis of Two Hundred and Sixty Contemporaneous Allogeneic Transplants From a Single Center

Asad Bashey, MD, PhD, Xu Zhang, PhD, Connie A. Sizemore, PharmD, Karen Manion, RN, Stacey Brown, BA, H. Kent Holland, MD, Scott R. Solomon, MD, Lawrence E. Morris, MD

Blood (2011) 118 (21): 833.

https://doi.org/10.1182/blood.V118.21.833.833

Published: 2011

Journal Articles

Haploidentical Transplantation Using T-Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors Is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of A Prospective Phase II Trial

Connie A. Sizemore, PharmD, Asad Bashey, MD, PhD, Melissa Sanacore, PharmD, Karen Manion, RN, H. Kent Holland, MD, Lawrence E. Morris, MD, Stacey Brown, B.A., Xu Zhang, PhD, Scott R. Solomon, MD

Blood (2011) 118 (21): 889.

https://doi.org/10.1182/blood.V118.21.889.889

Published: 2011

Journal Articles

Low Dose Subcutaneous Alemtuzumab and Preemptive Donor Lymphocyte Infusion without Withdrawal of Immunosuppression Results in Low Non-Relapse Mortality, Decreased Hospitalization, and Favorable Outcomes for High Risk Older Recipients of Unrelated Donor Allogeneic Transplants: A Prospective Phase II Trial

Connie A. Sizemore, PharmD, Asad Bashey, MD, PhD, Karen Manion, RN, H. Kent Holland, MD, Lawrence E. Morris, MD, Stacey Brown, BA, Xu Zhang, PhD, Scott R. Solomon, MD

Blood (2011) 118 (21): 3016.

https://doi.org/10.1182/blood.V118.21.3016.3016

Published: 2011

Journal Articles

Total Outpatient Care for Myeloablative Unrelated Donor Hematopoietic Cell Transplantation: A Safe and Effective Alternative to Standard In-Patient Care

Connie A. Sizemore, Pharm.D., Karen Manion, RN, Lawrence Morris, MD, Asad Bashey, MD, PhD, H. Kent Holland, MD, Scott R. Solomon, MD

Blood (2010) 116 (21): 3525.

https://doi.org/10.1182/blood.V116.21.3525.3525

Published: 2010

Journal Articles

Improved Survival using Dual Monoclonal Antibody Therapy with Aggressive Anti-Microbial Prophylaxis In Steroid-Refractory Acute Graft-Versus-Host Disease

Melissa Sanacore, PharmD, Karen Manion, RN, Pauline Smith, RN, Xu Zhang, PhD, H. Kent Holland, MD, Lawrence Morris, MD, Scott R. Solomon, MD, Asad Bashey, MD, PhD

Blood (2010) 116 (21): 1262.

https://doi.org/10.1182/blood.V116.21.1262.1262

Published: 2010

Journal Articles

Relative Impact of Psychosocial Factors, Comorbidities, and Disease Risk on the Utilization of Resources and Overall Outcome in Patients Undergoing Hematopoietic Stem Cell Transplantation

Dawn S Speckhart, Ph.D., H. Kent Holland, MD, Scott R. Solomon, MD, Lawrence E. Morris, Asad Bashey, MD, PhD, Leslie Kerns, RN, Tina Berry, MS, Karen Manion, RN

Blood (2008) 112 (11): 2404.

https://doi.org/10.1182/blood.V112.11.2404.2404

Published: 2008

Journal Articles

Outpatient Management of Both Myeloablative and Reduced-Intensity Allogeneic HCT Results in Low Non-Relapse Mortality Irrespective of HCT-CI.

Asad Bashey, MD, PhD, Karen Manion, RN, Lawrence E. Morris, MD, Kent Holland, MD, Gerard Conaghan, MD, Rebekkah Matthews, PharmD, Amy Dooley, PharmD, Connie Sizemore, PharmD, Leslie Kerns, RN, Scott R. Solomon, MD

Blood (2007) 110 (11): 3022.

https://doi.org/10.1182/blood.V110.11.3022.3022

Published: 2007

Journal Articles

Outpatient Busulfan (BU)/Cytoxan (CY)/VP-16 and Autologous Stem Cell Transplant (ASCT) for Non-Hodgkin’s Lymphoma (NHL) and Hodgkin’s Disease (HD): Comprehensive Supportive Care Program Associated with Low Treatment Related Mortality and Hospital Utilization.

Scott R. Solomon, MD, Karen Manion, RN, Kathy McNatt, RN, Lawrence E. Morris, MD, Asad Bashey, MD, PhD, H. Kent Holland, MD

Blood (2007) 110 (11): 1908.

https://doi.org/10.1182/blood.V110.11.1908.1908

Published: 2007

NARROW

Lineage–Specific Chimerism and Incidence of Graft-Failure Following T-Cell Replete Haploidentical Transplantation Using Post-Transplant Cyclophosphamide in Eighty-Nine Consecutive Patients From a Single-Center.

Haploidentical Transplantation Using T-Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors Is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of A Prospective Phase II Trial

Total Outpatient Care for Myeloablative Unrelated Donor Hematopoietic Cell Transplantation: A Safe and Effective Alternative to Standard In-Patient Care

Improved Survival using Dual Monoclonal Antibody Therapy with Aggressive Anti-Microbial Prophylaxis In Steroid-Refractory Acute Graft-Versus-Host Disease

Relative Impact of Psychosocial Factors, Comorbidities, and Disease Risk on the Utilization of Resources and Overall Outcome in Patients Undergoing Hematopoietic Stem Cell Transplantation

Outpatient Management of Both Myeloablative and Reduced-Intensity Allogeneic HCT Results in Low Non-Relapse Mortality Irrespective of HCT-CI.

Outpatient Busulfan (BU)/Cytoxan (CY)/VP-16 and Autologous Stem Cell Transplant (ASCT) for Non-Hodgkin’s Lymphoma (NHL) and Hodgkin’s Disease (HD): Comprehensive Supportive Care Program Associated with Low Treatment Related Mortality and Hospital Utilization.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only